Page 3 - Nasdaq Prph News Today

StockNews.com assumed coverage on shares of ProPhase Labs (NASDAQ:PRPH – Get Rating) in a report released on Saturday. The firm set a “sell” rating on the stock. Several other equities research analysts have also commented on PRPH. TheStreet lowered shares of ProPhase Labs from a “b-” rating to a “c+” rating in a research note […]

ProPhase Labs (NASDAQ:PRPH – Get Rating) had its price objective reduced by research analysts at HC Wainwright from $16.00 to $14.00 in a research report issued on Monday, The Fly reports. HC Wainwright’s target price would suggest a potential upside of 89.45% from the stock’s current price. A number of other brokerages also recently weighed […]

ProPhase Labs, Inc. (NASDAQ:PRPH – Get Rating) was the target of a large drop in short interest in the month of April. As of April 15th, there was short interest totalling 71,000 shares, a drop of 31.2% from the March 31st total of 103,200 shares. Based on an average trading volume of 25,000 shares, the […]

Equities research analysts forecast that ProPhase Labs, Inc. (NASDAQ:PRPH – Get Rating) will post sales of $24.31 million for the current fiscal quarter, according to Zacks Investment Research. Two analysts have made estimates for ProPhase Labs’ earnings. The highest sales estimate is $32.05 million and the lowest is $16.57 million. ProPhase Labs posted sales of […]

Equities analysts expect ProPhase Labs, Inc. (NASDAQ:PRPH – Get Rating) to post $0.39 earnings per share (EPS) for the current fiscal quarter, Zacks reports. Two analysts have provided estimates for ProPhase Labs’ earnings, with estimates ranging from $0.30 to $0.47. ProPhase Labs posted earnings per share of $0.23 during the same quarter last year, which […]

StockNews.com started coverage on shares of ProPhase Labs (NASDAQ:PRPH – Get Rating) in a research note issued to investors on Monday. The brokerage set a “sell” rating on the stock. PRPH has been the topic of several other research reports. TheStreet raised shares of ProPhase Labs from a “d+” rating to a “c-” rating in […]

Brokerages expect ProPhase Labs, Inc. (NASDAQ:PRPH – Get Rating) to report $24.31 million in sales for the current fiscal quarter, Zacks Investment Research reports. Two analysts have made estimates for ProPhase Labs’ earnings. The highest sales estimate is $32.05 million and the lowest is $16.57 million. ProPhase Labs posted sales of $15.27 million in the […]

StockNews.com started coverage on shares of ProPhase Labs (NASDAQ:PRPH – Get Rating) in a research note published on Sunday. The brokerage issued a sell rating on the stock. PRPH has been the subject of several other research reports. TheStreet raised shares of ProPhase Labs from a d+ rating to a c- rating in a research […]

ProPhase Labs (NASDAQ:PRPH – Get Rating) will be announcing its earnings results before the market opens on Wednesday, March 30th. Analysts expect the company to announce earnings of $0.36 per share for the quarter. Investors that are interested in participating in the company’s conference call can do so using this link. NASDAQ PRPH opened at […]

StockNews.com began coverage on shares of ProPhase Labs (NASDAQ:PRPH – Get Rating) in a note issued to investors on Saturday. The firm set a “sell” rating on the stock. A number of other analysts have also weighed in on the stock. HC Wainwright increased their price objective on shares of ProPhase Labs from $12.00 to […]